题目详情
多选题 In April 2017, US FDA allowed marketing of first direct-to-consumer tests that provide risk information for 10 diseases or conditions, including
A. Parkinson's disease, a nervous system disorder impacting movement
B. late-onset Alzheimer's disease, a progressive brain disorder that destroys memory and thinking skills
C. celiac disease, a disorder resulting in the inability to digest gluten
D. α1 antitrypsin deficiency, a disorder that raises the risk of lung and liver disease

学科:Bioethics 《生物伦理学》全英教学专业基础课
时间:2024-09-19 12:02:25
相关题目
相关作业
